NextCell Pharma AB Working Capital to Net Assets Ratio
NextCell Pharma AB working capital to net assets ratio. NextCell Pharma AB (NXTCL) has a Working Capital to Net Assets ratio of 73.8% as of August 2025. Working capital of Skr48.97 Million (current assets of Skr54.40 Million minus current liabilities of Skr5.43 Million) is measured against net assets of Skr66.39 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check NextCell Pharma AB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of NextCell Pharma AB (2015–2025)
Working capital to net assets ratio of NextCell Pharma AB from 2015 to 2025. This chart shows how NextCell Pharma AB's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of August 2025, the ratio stands at 73.8%, reflecting working capital of Skr48.97 Million against net assets of Skr66.39 Million SEK. See NextCell Pharma AB (NXTCL) liquidity interval to measure how many days the company can operate on defensive assets alone.
NextCell Pharma AB Working Capital to Net Assets Ratio by Year (2015–2025)
NextCell Pharma AB working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for NextCell Pharma AB from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see NXTCL total assets.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 73.8% | Skr48.97 Million | Skr66.39 Million | Skr54.40 Million | Skr5.43 Million | ▼ -1.3 pp |
| 2024 | 75.1% | Skr50.75 Million | Skr67.60 Million | Skr60.62 Million | Skr9.87 Million | ▼ -0.4 pp |
| 2023 | 75.5% | Skr57.19 Million | Skr75.73 Million | Skr67.27 Million | Skr10.08 Million | ▼ -10.9 pp |
| 2022 | 86.4% | Skr99.82 Million | Skr115.54 Million | Skr106.75 Million | Skr6.93 Million | ▼ -8.6 pp |
| 2021 | 95.0% | Skr142.52 Million | Skr150.09 Million | Skr146.48 Million | Skr3.96 Million | ▲ +4.0 pp |
| 2020 | 91.0% | Skr23.86 Million | Skr26.22 Million | Skr26.03 Million | Skr2.17 Million | ▲ +2.2 pp |
| 2019 | 88.8% | Skr20.38 Million | Skr22.96 Million | Skr23.20 Million | Skr2.82 Million | ▲ +42.4 pp |
| 2018 | 46.3% | Skr2.33 Million | Skr5.04 Million | Skr5.04 Million | Skr2.71 Million | ▼ -37.6 pp |
| 2017 | 83.9% | Skr16.00 Million | Skr19.07 Million | Skr17.86 Million | Skr1.86 Million | ▲ +18.2 pp |
| 2016 | 65.7% | Skr4.44 Million | Skr6.76 Million | Skr6.44 Million | Skr2.00 Million | ▼ -9.1 pp |
| 2015 | 74.8% | Skr7.31 Million | Skr9.77 Million | Skr9.18 Million | Skr1.87 Million | — |